North American study and meta-analysis evaluating performance of Bladder EpiCheck, a FDA cleared test, in non-muscle invasive bladder cancer recurrence

Background Bladder EpiCheck (BE) is a novel methylation-based PCR urine test for the detection of non-muscle invasive bladder cancer (NMIBC) recurrences. Objective We present the results of a North American study evaluating BE and meta-analysis of literature. Methods A prospective, blinded, multicen...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Neil Fleshner, Herbert Barton Grossman, Ryan Berglund, Jason Hafron, Brant Inman, Lawrence Karsh, Kelvin Moses, Daniel Saltzstein, Anup Shah, Jonathan Wright, Johannes Alfred Witjes, Yair Lotan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2024-12-01
coleção:	Bladder Cancer
Acesso em linha:	https://doi.org/10.1177/23523735241304348
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!